1.0400
-0.0700
(-6.31%)
At close: January 10 at 4:00:00 PM EST
1.0415
+0.00
+(0.14%)
After hours: January 10 at 6:36:50 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-8,452.0000
-7,586.0000
-1,539.0000
-695.0000
Investing Cash Flow
--
3,646.0000
-3,541.0000
-17.0000
-9.0000
Financing Cash Flow
--
3,895.0000
3,695.0000
11,902.0000
508.0000
End Cash Position
--
2,640.0000
3,543.0000
11,063.0000
699.0000
Capital Expenditure
--
-29.0000
-70.0000
-17.0000
-9.0000
Issuance of Capital Stock
--
3,970.0000
--
9,864.0000
508.0000
Repayment of Debt
--
-80.0000
-79.0000
--
--
Free Cash Flow
--
-8,481.0000
-7,656.0000
-1,556.0000
-704.0000
12/31/2020 - 12/9/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ADIL Adial Pharmaceuticals, Inc.
1.0200
-0.97%
MEIP MEI Pharma, Inc.
2.7000
+1.50%
SCNI Scinai Immunotherapeutics Ltd.
3.5300
+1.44%
ALZN Alzamend Neuro, Inc.
1.1300
-0.88%
SLGL Sol-Gel Technologies Ltd.
1.0450
-5.86%
IMMX Immix Biopharma, Inc.
2.1000
-6.67%
IKT Inhibikase Therapeutics, Inc.
2.9500
-4.84%
ENTO Entero Therapeutics, Inc.
0.5899
-4.85%
XLO Xilio Therapeutics, Inc.
1.1000
-1.79%
SLNO Soleno Therapeutics, Inc.
43.11
-3.17%